REQUEST A DEMO
Total
USD $0.00
Search more companies

Daehwa Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daehwa Pharm Co.,Ltd. Profile Updated: August 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Daehwa Pharm Co., Ltd. is a pharmaceutical company located in Gangwon-Do, South Korea. The company actively responds to the rapidly changing pharmaceutical industry by conducting research and development of new products, studying new formulations, and researching the formulation technology of existing products. Their efforts are aimed at respecting human life and promoting the healthy living of the nation. In order to enhance competitiveness and adapt to the changing pharmaceutical market in the 21st century, Daehwa Pharm has introduced advanced computer systems. They strive for efficient management and scientific rationalization throughout the entire management process, including electronic approval systems. By achieving quick business processing and accurate market analysis, they aim to develop sales strategies and achieve customer satisfaction. Daehwa Pharm's new corporate identity (CI) represents their philosophy of respecting human life and being environmentally friendly, as well as their advanced technological capabilities in leading pharmaceutical technology. The CI symbolizes the infinite connection between humanity, the environment, and technology, reflecting Daehwa Pharm's spirit of leading change in these areas, particularly for the health and happiness of humanity. It also symbolizes the company's commitment to the sustainability of the business and the infinite possibilities of life extension technology. The company's spot color is used for special printing purposes, and the symbol's shading is represented by shade (overprint), while the logo color is black. The symbol mark of Daehwa Pharm is the representative form of the company's identity and is used as a basic element in various communication media such as products, forms, promotional materials, and signage. The symbol mark should always be used in accordance with the proportional regulations and usage regulations to maintain the company's identity. Overall, Daehwa Pharm Co., Ltd. is a pharmaceutical company that focuses on research and development, formulation technology, and efficient management to meet the demands of the global pharmaceutical market and contribute to the health and well-being of the nation.

Headquarters
308 Masan-Ri, Hoengsung-Eup, Hoengsung-Gun
Gangwon-Do; Postal Code: 225-804

Contact Details: Purchase the Daehwa Pharm Co.,Ltd. report to view the information.

Website: http://www.dhpharm.co.kr

Basic Information
Total Employees:
Purchase the Daehwa Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Daehwa Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Daehwa Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Daehwa Pharm Co.,Ltd. report to view the information.
Incorporation Date:
January 19, 1989
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
11.44%
Purchase this report to view the information.
11.42%
Purchase this report to view the information.
8.15%
Purchase this report to view the information.
6.69%
Purchase this report to view the information.
0.75%
Subsidiaries
(주)리독스바이오
(주)스페셜라이즈드메드
Bsc Medical Devices Gmbh
Company Performance
Financial values in the chart are available after Daehwa Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.18%
Total operating revenue
2.97%
Operating profit (EBIT)
-56.45%
EBITDA
-30.12%
Net Profit (Loss) for the Period
N/A
Total assets
6.91%
Total equity
-6.79%
Operating Profit Margin (ROS)
-3.92%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
34.66%
Quick Ratio
-0.13%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?